South Korea Blood-based Biomaker For Sports Medicine Market Size & Outlook
South Korea blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
South Korea blood-based biomaker for sports medicine market highlights
- The South Korea blood-based biomaker for sports medicine market generated a revenue of USD 11.6 million in 2023 and is expected to reach USD 19.2 million by 2030.
- The South Korea market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 11.6 million |
| Market revenue in 2030 | USD 19.2 million |
| Growth rate | 7.5% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.7% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 25.9 million by 2030.
Ck was the largest segment with a revenue share of 18.1% in 2023. Horizon Databook has segmented the South Korea blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea is witnessing a rise in sports-related injuries, particularly among elite athletes. According to a National Institutes of Health (NIH) report from February 2021, around 782 elite athletes participated in 46 sporting events, with 141 injuries recorded, representing an injury rate of 18.03%. Of these injuries, 121 athletes (15.47%) experienced at least one injury.
Male athletes accounted for 80 injuries (56.74%), while female athletes suffered 61 (43.26%). This increasing prevalence of sports injuries has heightened the demand for advanced medical solutions, including blood-based biomarkers, which are becoming an integral part of sports medicine in South Korea.
As South Korea continues to focus on the health & performance of its athletes, the market for blood-based biomarkers in sports medicine is expected to witness significant growth over the forecast period. This development reflects the country’s commitment to integrating cutting-edge medical technologies into its sports healthcare infrastructure, ensuring better care and enhanced performance for its athletes.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
South Korea Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
